Harmony Biosciences posts Q3 results, highlights BP-205 safety data
WAKIX net revenue reached $269 million in the quarter, and the company said it remains on track to meet full-year guidance of $1.0 billion to $1.04 billion.
SEC filing (2)
3 stories
WAKIX net revenue reached $269 million in the quarter, and the company said it remains on track to meet full-year guidance of $1.0 billion to $1.04 billion.
SEC filing (2)
The company filed terms of Jeffrey Dayno's separation and Peter Anastasiou's new employment agreement tied to the CEO succession announced October 12, 2026.
SEC filing
Harmony's board set a leadership transition effective January 1, 2027, while reaffirming 2026 WAKIX revenue guidance and a pipeline data readout.
SEC filing